Stay updated with breaking news from Psychedelic Research. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
- Amir Inamdar, Chief Medical Officer, to appear on panel discussions on June 5 and June 8 - - Ellen James, Director, Clinical Development, to present abstract titled "SPL026 (DMT fumarate) in combination
An inspiring engagement following the quickly developing technology of psychedelic meds
A psychiatrist explores ketamine-assisted psychotherapy in this ongoing series.
VANCOUVER, British Columbia, April 24, 2024 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “AGN Pharma”) (CSE: AGN) (FRANKFURT:...
However, psychedelic medicine has a variety of barriers, including historical perception, access challenges, legal obstacles, and ethical questions.